✦ LIBER ✦

Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study

✍ Scribed by Herrero, Carlos Camps; Noguerón Martı́nez, Esther; Jaime, Alfonso Berrocal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Corrigendum to “Second line treatment wi

✍ Camps, Carlos; Noguerón Martı́nez, Esther; Berrocal Jaime, Alfonso 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Cisplatin and vinorelbine as second-line

✍ De Pas, Tommaso; de Braud, Filippo; Mandalà, Mario; Curigliano, Giuseppe; Catani 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 55 KB

First-line treatment of advanced non-sma

✍ Beinert, T; Schweigert, M; Kahnt, C; Fleischhacker, M; Werner, T.G; Binder, D; M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A phase II study with vinorelbine, gemci

✍ Ginopoulos, P.; Mastronikolis, N.S.; Giannios, J.; Karana, A.; Siabi, V.; Karvel 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Non-cisplatin-based chemotherapy for adv

✍ Rodríguez, R; Fírvada, JL; Mel, JR; Castellanos, J; Salgado, M; Mata, JG; Quinte 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Gemcitabine (GEM) as single agent in sec

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB